The ADRC provides specialized resources to accelerate research on the role of metabolic and vascular factors in the causes of Alzheimer’s disease and for the development of novel interventions.
- Annual pilot grants that fund approximately $40K every year for two to four projects.
- Clinical, cognitive and neuroimaging data as well as DNA, blood and cerebrospinal fluid from approximately 1,000 well-characterized participants. Approximately 1,000 more participants will be added over the next two to three years, with an emphasis on minority subjects and those with mild cognitive impairment.
- Database of longitudinal clinical trial participants with and without metabolic disorders and cardiovascular disease, who range from normal cognition and mild cognitive impairment, to Alzheimer’s disease or mixed dementia, and who may be available for other clinical trials.
- A human brain bank under development at Wake Forest School of Medicine. Our affiliated brain bank at the University of Washington offers prioritized access to Wake Forest investigators, with over 600 well-characterized cases.
- A repository of non-human primate biospecimens, data and neuroimaging from multiple studies, many of which parallel human metabolic disorders, aging and Alzheimer’s disease neuropathology.
- Access to Alzheimer’s disease repositories and data through the National Alzheimer’s Coordinating Center (NACC), National Cell Repository for AD (NCRAD) and AD Genetics Consortium (ADGC).
- Education and training for community health care professionals and the public about early detection, prevention and treatment of Alzheimer’s.
The Wake Forest Alzheimer's Disease Research Center issues a Request for Applications for pilot grants each fall.